SCHEMBL21691610

SCHEMBL21691610

N#Cc1ccc2sc3ccc(-c4cc(-c5ccc6sc7ccc(C#N)cc7c6c5)cc(-c5c(C#N)cccc5-c5ccccc5)c4)cc3c2c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
G6PD P11413 2/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
FASN P49327 1/20 0.36
SSTR2 P30874 1/20 0.34
ESR2 Q92731 1/20 0.34
CHEK1 O14757 1/20 0.34
PRKDC P78527 1/20 0.33
PDK2 Q15119 1/20 0.33
CSF1R P07333 1/20 0.32
GABRA1 P14867 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA2 P47869 2/20 0.32
ALDH1A1 P00352 1/20 0.32
ATM Q13315 1/20 0.32
STS P08842 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
MAP4K4 O95819 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21691611 0.97 G6PD (0.36) G6PDMEN1KMT2AFASNSSTR2
SCHEMBL21692443 0.91 SLC22A12 (0.36) FASNSSTR2ESR2CHEK1GABRG2
SCHEMBL21692218 0.89 PIM3 (0.37) FASNSSTR2ESR2CHEK1ALDH1A1
SCHEMBL21691605 0.89 ADRA2C (0.38) FASNCHEK1PRKDCPDK2GABRG2
SCHEMBL21691553 0.88 GABRG2 (0.41) MEN1KMT2AESR2GABRA1GABRG2
SCHEMBL21692356 0.87 F9 (0.36) FASNSSTR2ESR2CHEK1GABRG2
SCHEMBL21692444 0.86 SLC22A12 (0.36) FASNSSTR2ESR2GABRG2GABRB3
SCHEMBL21692442 0.85 G6PD (0.38) G6PDMEN1KMT2AFASNGABRA1
SCHEMBL21691520 0.85 ESR2 (0.42) G6PDMEN1KMT2AESR2GABRA1
SCHEMBL21691544 0.85 GABRG2 (0.39) MEN1KMT2AESR2GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 G6PD 4394/4885MEN1 556/4885KMT2A 1275/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 G6PD 4394/4885MEN1 556/4885KMT2A 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.